Gressier, Florence http://orcid.org/0000-0002-5160-9823
Letranchant, Aurélie
Glatigny-Dallay, Elisabeth
Falissard, Bruno
Sutter-Dallay, Anne-Laure
Article History
Received: 12 March 2019
Accepted: 1 July 2019
First Online: 11 July 2019
Compliance with ethical standards
:
: Regarding potential conflicts of interest, all of them were indirect: F. Gressier has given talks for Eisai, Lundbeck and Servier and received a Grant from Servier for a postdoctoral degree (2011–2012). B. Falissard has been a consultant, expert or has given talks for E. Lilly, BMS, Servier, Sanofi, GlaxoSmithKline, HRA, Roche, Boeringer Ingelheim, Bayer, Almirall, Allergan, Stallergene, Genzyme, Pierre Fabre, Astra Zeneca, Novartis, Janssen, Astellas, Biotronik, Daiichi-Sankyo, Gilead, MSD, and Lundbeck. A. Letranchant, E. Glatigny-Dallay and A. L. Sutter-Dallay report no financial relationships with commercial interests.